- Home
- KPTI vs EHGO Comparison
KPTI vs EHGO Comparison
Compare KPTI & EHGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KPTI
- EHGO
- Stock Information
- Founded
- KPTI 2008
- EHGO 2015
- Country
- KPTI United States
- EHGO China
- Employees
- KPTI 325
- EHGO N/A
- Industry
- KPTI Biotechnology: Pharmaceutical Preparations
- EHGO
- Sector
- KPTI Health Care
- EHGO
- Exchange
- KPTI Nasdaq
- EHGO NYSE
- Market Cap
- KPTI 105.9M
- EHGO 91.9M
- IPO Year
- KPTI 2013
- EHGO 2024
- Fundamental
- Price
- KPTI $0.85
- EHGO $3.75
- Analyst Decision
- KPTI Strong Buy
- EHGO
- Analyst Count
- KPTI 4
- EHGO 0
- Target Price
- KPTI $5.00
- EHGO N/A
- AVG Volume (30 Days)
- KPTI 1.1M
- EHGO 35.2K
- Earning Date
- KPTI 11-05-2024
- EHGO 12-03-2024
- Dividend Yield
- KPTI N/A
- EHGO N/A
- EPS Growth
- KPTI N/A
- EHGO N/A
- EPS
- KPTI N/A
- EHGO 0.00
- Revenue
- KPTI $148,442,000.00
- EHGO $16,963,957.00
- Revenue This Year
- KPTI $6.67
- EHGO N/A
- Revenue Next Year
- KPTI $8.58
- EHGO N/A
- P/E Ratio
- KPTI N/A
- EHGO $9,420.51
- Revenue Growth
- KPTI 1.77
- EHGO N/A
- 52 Week Low
- KPTI $0.62
- EHGO $1.45
- 52 Week High
- KPTI $1.95
- EHGO $4.40
- Technical
- Relative Strength Index (RSI)
- KPTI 50.60
- EHGO N/A
- Support Level
- KPTI $0.75
- EHGO N/A
- Resistance Level
- KPTI $0.95
- EHGO N/A
- Average True Range (ATR)
- KPTI 0.07
- EHGO 0.00
- MACD
- KPTI -0.01
- EHGO 0.00
- Stochastic Oscillator
- KPTI 46.97
- EHGO 0.00
About KPTI Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. XPOVIO (selinexor), is approved in the U.S. in multiple hematologic malignancy indications, including in combination with Velcade (bortezomib) and dexamethasone for the treatment of adult patients with multiple myeloma after at least one prior therapy, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma and as a monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma. The company derives its revenue from United States.
About EHGO ESHALLGO INC
Eshallgo Inc. focuses on two distinct market sectors: office supply sale and leasing, and after-sale maintenance and repair. It is an authorized distributor of brands of office equipment, including HP, Epson, Xerox, Sharp, Toshiba, Konica, Kyocera, and other brands.